Exbivirumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Exbivirumab ?
Monoclonal antibody
Type Whole antibody
Source Human
Target hepatitis B surface antigen
Clinical data
Legal status ?
Identifiers
CAS number 569658-80-6 N
ATC code None
Chemical data
Formula C6416H9924N1732O1982S44 
 N (what is this?)  (verify)

Exbivirumab is a human monoclonal antibody[1] developed for the treatment of hepatitis B infections.[2]

References[edit]

  1. ^ WHO Drug Information
  2. ^ Shouval, D; et al. (2006). "Anti-Viral Effects, Pharmacokinetics and Safety of Two Human Monoclonal Anti-Hbs (Libivirumab/Exbivirumab) Versus Hepatitis B Immune Globulin (Hbig) in Hepatits B Virus (Hbv) in Liver Transplant (Lt) Recipients". Hepatology 44 (4): 188A–700A [196A]. doi:10.1002/hep.21395. PMID 17001593.